Thanks Meteor. I understand the validation which if applied to predominantly diabetic and obese patients should reveal a high risk. The validation would be better if applied to a sample group not generally indicated as being at high risk (healthy looking people) who show signs of high risk and subsequently go onto develop CKD. It just seems like a test that confirms high risk if you're already in a high risk category. I'll leave it that. Thanks for all your feedback folks.
Thanks Meteor. I understand the validation which if applied to...
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
62.0¢ |
Change
-0.010(1.59%) |
Mkt cap ! $81.22M | |||
| Open | High | Low | Value | Volume |
| 63.0¢ | 63.0¢ | 55.0¢ | $571.7K | 964.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 59.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 62.0¢ | 9013 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |